IthaID: 3259

Names and Sequences

Functionality: Disease modifying mutation Pathogenicity: N/A
Common Name: rs2333227 HGVS Name: NG_009629.1:g.4535G>A

Context nucleotide sequence:

Also known as: -463G>A

Comments: Association with increased susceptibility to infections in a cohort of SCA children, suggesting a deleterious effect [PMID: 15996936]. Association with enhanced oxidative stress (higher AOPP levels) and with a delayed age of first complication in an independent cohort of SCA, which would rather suggest a protective effect [PMID: 32937882]. Association with lipid (i.e. total cholesterol and low-density lipoprotein cholesterol (LDL-C)) laboratory markers in SCA patients treated with hydroxyurea. Association with hepatic (i.e. globulin), inflammation (i.e. uric acid) and lipid/glycemic (i.e. glucose) laboratory markers in SCA patients not treated with hydroxyurea [PMID: 29619129].

We follow the HGVS sequence variant nomenclature and IUPAC standards.

External Links


Allele Phenotype (Cis):N/A
Allele Phenotype (Trans):N/A
Associated Phenotypes: Recurrent infections [HP:0002719]


Chromosome: 17
Locus: NG_009629.1
Locus Location: 4535
Size: 1 bp
Located at: MPO
Specific Location: Promoter

Other details

Type of Mutation: Point-Mutation(Substitution)
Effect on Gene/Protein Function: Promoter (Transcription)
Ethnic Origin: Brazilian
Molecular mechanism: N/A
Inheritance: Quantitative trait
DNA Sequence Determined: Yes

In silico pathogenicity prediction

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage. Otherwise, use this external link.

Publications / Origin

  1. Costa RN, Conran N, Albuquerque DM, Soares PH, Saad ST, Costa FF, Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia., Haematologica , 90(7), 977-9, 2005 PubMed
  2. Yahouédéhou SCMA, Carvalho MOS, Oliveira RM, Santiago RP, da Guarda CC, Carvalho SP, Ferreira JRD, Aleluia MM, Adorno EV, Gonçalves MS, Sickle Cell Anemia Patients in Use of Hydroxyurea: Association between Polymorphisms in Genes Encoding Metabolizing Drug Enzymes and Laboratory Parameters., Dis. Markers, 2018(0), 6105691, 2018 PubMed
  3. Gueye Tall F, Martin C, Ndour EHM, Faes C, Déme Ly I, Pialoux V, Connes P, Gueye PM, Ndiaye Diallo R, Renoux C, Diagne I, Diop PA, Cissé A, Sall PL, Joly P, Influence of Oxidative Stress Biomarkers and Genetic Polymorphisms on the Clinical Severity of Hydroxyurea-Free Senegalese Children with Sickle Cell Anemia., Antioxidants (Basel), 9(9), 0, 2020 PubMed
Created on 2017-09-21 19:26:32, Last reviewed on 2022-10-27 14:23:38 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.